Ryder Capital Limited Overview
Ryder Capital Limited is a small but distinctive Australian listed investment company. Through a closed-end vehicle, it gives retail and wholesale investors access to a concentrated, high-conviction, value-driven portfolio of ASX small- and micro-cap equities. Ryder Investment Management, a Sydney boutique founded in 2008 by Peter Constable, manages the portfolio. The strategy targets absolute returns above the RBA cash rate plus 4.25% rather than tracking an index. It typically holds about 25–35 positions, and the top ten holdings often exceed 60% of capital.
FY26 was the third consecutive year of net returns above 25%:
-
Pre-tax NTA return of 33.53%
-
Gross portfolio return of 37.59%, against 8.11% for the Small Ordinaries Accumulation Index
-
Record total comprehensive income of A$31.80m
The manager owns about 22.7% of the shares through director-related interests, which creates strong alignment. The trade-offs are key-person concentration, limited board independence, and a high-fee structure (1.25% management fee plus a 20% performance fee).
What the company does
Ryder Capital is a pure investment holding company. Its sole activity is investing a concentrated portfolio of ASX-listed small- to mid-capitalisation securities, plus bonds and cash. It may also hold unlisted securities and derivatives (options and warrants) incidental to its equity positions.
In its FY26 Directors' Report, the Company describes its principal activity as investing in such a portfolio in line with its permitted investments. Its objective is long-term capital growth above its benchmark (RBA cash rate plus 4.25% p.a.), under the 12 August 2015 Prospectus. Day-to-day investment decisions sit with the external Investment Manager.
Business model and "revenue" model
| Economic lever | Description | FY26 figure (AUD) | FY25 figure (AUD) | Source |
|---|---|---|---|---|
| Dividend income (net of franking) | Dividends from investee companies | 2,444,350 | 2,681,391 | FY26 P&L |
| Interest income | Interest on cash (weighted average rate 3.68% at June 2026) | 770,127 | 598,883 | FY26 P&L, Note 2 |
| Net gain on FVTPL instruments | Mark-to-market on options and warrants | 1,360,159 | 668,315 | FY26 P&L |
| Other income | Sundry | 526 | 4,287 | FY26 P&L |
| Total investment income ("revenue from ordinary activities") | — | 4,575,162 | 3,952,876 | FY26 Appendix 4E |
| Movement in fair value of long-term equity investments (OCI, net of tax) | Realised and unrealised gains on the core portfolio, taken through OCI under the AASB 9 FVOCI election | 31,368,841 | 19,594,671 | FY26 P&L/OCI |
| Total comprehensive income | Headline economic measure | 31,800,237 | 21,813,017 | FY26 P&L/OCI |
An LIC has no products or customers in the conventional sense. Its economics work as follows:
Accounting mechanics. The Company has irrevocably elected to measure its long-term equity investments at fair value through other comprehensive income (FVOCI). As a result, realised and unrealised capital gains on the portfolio bypass statutory profit. Statutory net profit (A$0.43m in FY26) therefore captures only income less expenses and tax. It is a poor guide to economic performance, and management itself directs investors to total comprehensive income.
Realised gains after tax are transferred within equity, from the asset revaluation reserve to a capital profits reserve. That reserve then funds dividends. In FY26, A$25.19m of realised after-tax gains moved into the capital profits reserve, which closed at A$47.61m.
Cost structure. Costs comprise:
-
A management fee of 1.25% p.a. plus GST on portfolio net asset value
-
A performance fee of 20% plus GST of outperformance over the benchmark. It accrues monthly, is paid annually, and carries forward any deficit (a high-water-mark style mechanism)
-
Directors' fees (A$80,000 in FY26)
-
Portfolio management expense recoveries (A$254,555)
-
Other operating costs (A$395,828)
Total FY26 expenses were A$5.06m, of which the performance fee accounted for A$2.18m.
Value-chain position, customers and end-markets
| Dimension | Characterisation |
|---|---|
| Value-chain position | A permanent-capital provider to the ASX small/micro-cap market. It provides IPO and placement capital (for example the FDC Consolidated IPO in June 2026 and the Tetratherix IPO in July 2025) and acts as a significant, sometimes engaged, shareholder in investee companies |
| "Customers" (capital providers) | Australian retail investors, self-managed super funds (SMSFs), high-net-worth individuals, and the manager and directors themselves (about 22.7% of shares) |
| End-markets of exposure (30 June 2026 sector mix) | Materials 20.8%, Financial Services 20.1%, Technology 18.9%, Industrials 13.0%, Healthcare 12.3%, Consumer Discretionary 3.8%, Media & Entertainment 2.9%, Energy 1.2%, Cash 6.9% (FY26 Annual Report) |
| Value proposition to shareholders | Fully franked dividend income (12 cps p.a.), capital growth, and access to concentrated small-cap expertise. The closed-end structure suits illiquid micro-caps because it avoids redemption pressure |
Independent characterisation
Ryder is a high-conviction, benchmark-agnostic, value-biased small-cap fund wrapped in an LIC. Its return profile is lumpy. Annual pre-tax undiluted NTA returns ranged from −21.47% (FY22) to +33.72% (FY21), per the September 2026 Shareholder Letter heatmap.
Its outcomes are driven by a few large positions:
FY26: Macmahon contributed about A$13.5m and BCI Minerals was 14.7% of the portfolio at June 2026.
September 2026: BCI had grown to 20.14% of the portfolio.
The manager is willing to hold unlisted and venture-like assets (Updater Technologies, and previously Vitrafy convertible notes). It participates in IPOs, uses options where they arise, and will exit on governance grounds (Humm Group in FY26).
Because the board is dominated by the manager's principals, governance looks more like a family-office vehicle than a widely held institutional LIC.
Strategy
Stated strategy (themes from the FY26 Annual Report and NTA reports)
Ryder's stated investment pillars, from its monthly NTA reports, are:
-
An absolute-return, value-driven, fundamental approach
-
Outperforming the RBA cash rate plus 4.25% over the medium to longer term
-
A concentrated, high-conviction portfolio of ASX small and micro-caps
-
Medium- to long-term capital growth
The manager describes its differentiation as a long holding horizon, meaningful co-investment in the Company, and putting absolute returns first. It attributes its success to avoiding mistakes, ignoring consensus, and backing its own judgement.
Initiatives in the last 24 months
| Date | Initiative | Detail / target | Status |
|---|---|---|---|
| 19 Feb 2024 | DRP launch | Allow reinvestment of dividends | Suspended 8 Jul 2025 (while shares traded at a wide discount, issuing scrip would have been dilutive) |
| FY25 to FY26 | On-market buy-back | 1,641,386 shares (FY25) and 450,000 (FY26) | Inactive since about January 2026 as the discount narrowed; to resume when meaningfully NTA-accretive |
| 15 Oct 2025 | Enhanced dividend policy | Quarterly 3.0 cps fully franked; 12 cps annualised (+20% on FY25); imputation rate raised to 30% | Implemented; four quarterly dividends declared so far (Dec-25, Mar-26, Jun-26, Sep-26) |
| FY26 | Portfolio rotation into "SaaSpocalypse" software | New positions in SiteMinder, Vista, Gentrack and Fineos | Mixed: Gentrack −73% in FY26; SiteMinder a detractor in Aug/Sep 2026 |
| FY26 | Profit realisation | Net A$35.98m realised gains, including the full Macmahon exit | Completed |
| FY26 to FY27 | Cash rebuild | Cash 6.89% at June 2026 seen as a low point; 8.85% at September 2026, still below target | Ongoing |
| FY26 | Governance refresh | New Company Secretary; auditor change to Pitcher Partners | Completed |
| Ongoing | ESG / sustainability programme | None disclosed | — |
| Ongoing | Cost programme | None disclosed; fees are contractual | — |
Medium-term targets and guidance
| Item | Target / guidance | Source |
|---|---|---|
| Return objective | Exceed RBA Cash Rate + 4.25% p.a. over the medium to long term | Prospectus |
| FY27 dividend | Minimum 3.0 cps per quarter fully franked (12.0 cps); "steady to increasing" over time | FY26 Annual Report |
| Dividend coverage | More than five years of fully franked dividend coverage from reserves and portfolio income. About A$0.73 per share profits reserve at 30 Sep 2026, of which about A$0.57 per share is distributable fully franked | FY26 Chairman's Letter; Sep-26 Letter |
| Return expectation | Management anticipates another strong year in FY27, describing the portfolio as cheap relative to intrinsic value | FY26 Investment Manager's Report |
| Earnings guidance | None (not applicable for an LIC) | — |
Products & Services
For an LIC, the "product" is the listed share (RYD) and the underlying investment strategy. The "catalog" is the investment portfolio. Both are set out below.
Listed product
| Product | Description | Target investor | Launch | Pricing / cost |
|---|---|---|---|---|
| RYD ordinary shares (ASX) | Closed-end exposure to the Ryder small-cap strategy with quarterly fully franked dividends | Retail, SMSF, HNW | 22 Sep 2015 | Market price (A$2.14 at 30 Sep 2026); 1.25% p.a. management fee plus 20% performance fee over RBA + 4.25% |
| RYDO / RYDOA options (historic) | Listed options issued around listing / follow-on; 26.7m and 26.5m exercised | Existing shareholders | c.2015 to 2016 (exact dates n/d) | Exercised; none outstanding (FY26 Note 10) |
| Dividend Reinvestment Plan | DRP commenced 19 Feb 2024 | Existing shareholders | Feb 2024 | Suspended since 8 Jul 2025 |
| On-market share buy-back | Accretive capital management | All holders (indirect) | Ongoing; 450,000 shares bought in FY26 at A$1.65 average | Inactive in 2H FY26 and the Sep-26 quarter as the discount narrowed |
Related manager product (not a Company product): the Ryder Innovation Fund, referenced in the FY26 report as the vehicle through which the manager first knew Tetratherix. Its details are not publicly disclosed in the sources reviewed.
Investment strategy specifications
| Attribute | Specification | Source |
|---|---|---|
| Style | Absolute-return, value-driven, fundamental, bottom-up | NTA reports |
| Universe | ASX-listed small and micro-caps; selective unlisted and pre-IPO | NTA reports; FY26 portfolio |
| Concentration | High conviction; 34 line items (about 30 issuers) at June 2026; top 10 equal to 62.6% of assets | FY26 portfolio table |
| Hurdle | RBA Cash Rate + 4.25% p.a. (about 8.85% at a 4.60% cash rate after the RBA's 29 Sep 2026 hike) | Sep-26 Shareholder Letter |
| Risk controls | Minimum "margin of safety" parameters; maximum single-stock and sector limits per Prospectus | FY26 Note 2(d) |
| Derivatives | Permitted for hedging, substitution and exposure management; in practice limited to options and warrants received | FY26 Note 8 |
| FX | May hedge; Updater US-dollar exposure unhedged | FY26 Note 3(d) |
| Gearing | None used | FY26 Balance Sheet |
Full portfolio catalog at 30 June 2026 (FY26 Annual Report)
| # | Holding | Ticker | Value (AUD) | Weight (%) | Business description (analyst summary) |
|---|---|---|---|---|---|
| 1 | BCI Minerals | BCI | 23,828,950 | 14.72 | Developer of the Mardie Salt & Sulphate of Potash Project, Western Australia |
| 2 | Count | CUP | 13,354,650 | 8.25 | Vertically integrated financial advice, wealth and accounting network |
| 3 | Vitrafy Life Sciences | VFY | 10,126,347 | 6.26 | Cryopreservation technology (Guardion units) for blood, cell & gene therapy and animal reproduction |
| 4 | Cuscal | CCL | 9,821,739 | 6.07 | Payments and banking infrastructure provider; acquired Indue and Paymark (NZ) |
| 5 | OFX Group | OFX | 9,410,039 | 5.81 | Cross-border payments; subject to a A$1.00 cash proposal from Equals |
| 6 | Chrysos Corporation | C79 | 9,382,040 | 5.80 | PhotonAssay technology replacing fire assay in mineral testing |
| 7 | Lumos Diagnostics | LDX | 8,324,788 | 5.14 | Point-of-care diagnostics; FebriDX received CLIA Waiver in March 2026 |
| 8 | SiteMinder | SDR | 7,334,934 | 4.53 | Hotel distribution and channel-management software |
| 9 | Fineos Corporation | FCL | 5,185,950 | 3.20 | Core systems software for life, accident and health insurers |
| 10 | Updater Technologies (Series A Pref) | Unlisted | 4,945,980 | 3.06 | US relocation/HOME platform (Delaware) |
| 11 | Polymetals Resources | POL | 4,752,472 | 2.94 | Base/precious metals producer (exited Sep-26 qtr) |
| 12 | Gentrack | GTK | 4,474,702 | 2.76 | Utility billing and airport software |
| 13 | Symal Group | SYL | 4,133,377 | 2.55 | Civil infrastructure contractor |
| 14 | SRG Global | SRG | 3,984,665 | 2.46 | Engineering and maintenance services |
| 15 | Coast Entertainment | CEH | 3,892,684 | 2.40 | Theme parks, Gold Coast (exited Sep-26 qtr) |
| 16 | Airtasker | ART | 3,888,585 | 2.40 | Services marketplace (Australia, UK, US) |
| 17 | FDC Consolidated | FDC | 3,562,500 | 2.20 | IPO June 2026, listed 9 July 2026 (exited Aug-26) |
| 18 | Hillgrove Resources (now Kantra Copper) | HGO | 2,635,590 | 1.63 | South Australian copper producer |
| 19 | Vista Group | VGL | 2,515,188 | 1.55 | Cinema-industry software (NZ/ASX) |
| 20 | Nufarm | NUF | 2,287,470 | 1.41 | Crop protection and seed technologies (exited Sep-26 qtr) |
| 21 | Adore Beauty Group | ABY | 2,285,896 | 1.41 | Online and physical beauty retail |
| 22 | Janison Education Group | JAN | 2,229,306 | 1.38 | Digital assessment platform |
| 23 | Urbanise.com | URB | 1,552,878 | 0.96 | Strata/facilities management SaaS |
| 24 | Amplitude Energy | AEL | 1,546,493 | 0.96 | East-coast gas producer |
| 25 | Tetratherix | TTX | 961,680 | 0.59 | Biomaterials / medtech (IPO July 2025) |
| 26 | Updater Technologies (Common) | Unlisted | 926,765 | 0.57 | As above |
| 27 | Updater Technologies (Warrants) | Unlisted | 884,710 | 0.55 | As above; strike US$0.75, expiring June 2029 |
| 28 | Commschoice Group | CCG | 807,500 | 0.50 | Telecommunications / cloud communications |
| 29 | 3P Learning | 3PL | 607,697 | 0.38 | Online education (Mathletics) |
| 30 | Lumos Diagnostics (Options) | Unlisted | 546,352 | 0.34 | Exercised September 2026 at 7 cents |
| 31 | Omega Oil & Gas | OMA | 373,215 | 0.23 | Queensland gas exploration |
| 32 | Valiant Gold | VAL | 133,333 | 0.08 | Gold exploration |
| 33 | Tubi | Unlisted | 37,474 | 0.02 | In members' voluntary liquidation (about 1.6 cents expected return) |
| 34 | Duratec | DUR | 1,012 | 0.01 | Asset remediation contractor (residual) |
| — | Total equities | — | 150,736,961 | 93.11 | — |
| — | Cash (incl. settlements/receivables) | — | 11,147,081 | 6.89 | — |
Key position weights at 30 September 2026 (Sep-26 Shareholder Letter)
| Holding | Weight (%) | Quarterly move (as reported) |
|---|---|---|
| BCI Minerals | 20.14 | +57.0% |
| Count | 8.80 | +42.2% (incl. dividends) |
| Vitrafy Life Sciences | 7.25 | +32.9% |
| Cuscal | 6.47 | +23.7% (incl. dividends) |
| Chrysos | 5.78 | +14.5% |
| OFX Group | 5.68 | +10.8% |
| Lumos Diagnostics | 5.00 | −4.8% |
| Cash | 8.85 | — |
New small positions in the September 2026 quarter: Objective Corporation, SCX.AI, Mitchell Services and Generation Development Group, together about 1.8% of the portfolio.
Exits in July to September 2026: FDC Consolidated, Nufarm, Coast Entertainment and Polymetals Resources.
Financial Narrative
Data conventions:
-
"n/d" means not publicly disclosed in the sources reviewed.
-
FY2025 and FY2026 are audited (FY26 Annual Report).
-
FY2022 to FY2024 come from the FY26 Remuneration Report five-year table, prior releases, or InvestSMART (flagged in the notes).
-
An LIC has no gross profit, EBITDA, capex or goodwill in the conventional sense. Those lines are shown as 0 or n/a with explanation.
Income statement
Notes to 6.1:
-
Statutory net profit and dividends declared per share are from the FY26 Remuneration Report five-year table.
-
FY23 and FY24 investment income and EPS are InvestSMART aggregates, not reconciled to audited statements.
-
FY24 total comprehensive income (≈18.2) is derived from the FY25 release's "+20% to A$21.8m". A Quartr summary describes FY24 income as up 363%. Because the FY23 NTA return was negative (−8.85%), that growth rate cannot be reconciled reliably, so FY23 total comprehensive income is left as n/d.
Dividend timing: "Dividends declared" in FY26 (9.0 cps) reflects the switch to quarterly declarations: three 3.0 cps dividends were declared within FY26, and the June-quarter dividend was declared on 1 July 2026. Dividends paid in FY26 were 11.5 cps (the 5.5 cps FY25 final plus two quarterlies), per the FY26 Directors' Report.
Margins and growth (analyst-computed from audited data)
Average net assets: FY25 = (114.29 + 126.69)/2 = A$120.49m; FY26 = (126.69 + 148.46)/2 = A$137.57m.
Commentary. The headline driver in FY26 was the A$31.37m fair-value uplift through OCI. Within it, the portfolio realised A$35.98m of net gains (A$38.79m gross gains, A$2.81m gross losses). Statutory profit fell 80.6% to A$0.43m. The reason was the A$2.18m performance fee, which crystallised after the carried-forward deficit of A$4.61m at June 2025 was fully recovered. Statutory profit does not reflect weaker operations.
The effective tax rate of −189% reflects franking-credit offsets against a small pre-tax loss. Gross margin, operating margin and EBITDA margin are not meaningful for an LIC. Investment income growth of 15.7% came mainly from higher interest income on larger cash balances and higher FVTPL option gains; dividend income was lower.
Balance sheet
Notes to 6.3:
-
FY23 equity is from InvestSMART.
-
FY24 equity, cash and current tax are from the FY26 Statement of Changes in Equity, Cash Flow Statement and Note 4 opening balances.
-
FY22/FY23 NTA figures are from the FY26 Remuneration Report and the FY23 Appendix 4E comparatives.
-
The FY25 net deferred tax figure is a net deferred tax asset of A$0.28m.
-
Distributable profit reserves per share are read from the FY26 Directors' Report chart.
Equity composition at 30 June 2026 (A$):
The swing from a A$1.10m deficit to a A$5.08m surplus in the revaluation reserve shows that unrealised gains are now embedded in the book.
Fair value hierarchy at 30 June 2026 (A$):
Level 3 assets more than doubled from A$2.68m, after an independent limited-scope valuation of Updater at a 17.5% discount rate and 2.5% terminal growth.
Cash flow
FY23/FY24 operating, investing and financing flows are InvestSMART rounded aggregates. Dividends paid FY22 to FY24 are from the FY26 Remuneration Report. For an LIC, "free cash flow" is defined here as operating plus net investing flows, since portfolio turnover is the business. This is an analyst definition.
Commentary. Operating cash flow turned negative mainly because tax paid on realised gains rose: tax paid of A$6.58m in FY26 versus A$2.62m in FY25. Realised gains are taxed but sit in investing flows, while the tax on them sits in operating flows. Net portfolio realisations (A$21.6m) comfortably funded A$9.29m of dividends and A$0.87m of buy-backs, and still lifted cash by A$4.98m.
Tax paid feeds the franking account. The account closed FY26 at A$10.95m, rising to A$19.28m adjusted for current tax payable. This is the engine behind the 12 cps fully franked dividend commitment.
Performance history (economic "top line")
Sources: the Sep-26 Shareholder Letter heatmap (undiluted, FY22 to FY26), the FY25 Appendix 4E and the FY26 Annual Report.
Pre-tax NTA per share CAGR, FY22 to FY26: about 9.9% a year, before adding back dividends paid (computed: (1.9805/1.36)^(1/4) − 1). Including dividends, the reported 5-year pre-tax undiluted NTA return to June 2026 was 8.69% p.a. The difference reflects the FY22/FY23 drawdowns falling at the start of the window.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Ownership / control |
|---|---|---|
Ryder Capital Limited | ASX-listed LIC; holds all investments | Public shareholders; directors and related parties hold about 22.7% |
Ryder Investment Management Pty Ltd | External Investment Manager (AFSL 328 971); earns management and performance fees; holds 4,194,000 RYD shares | Privately owned; controlled by Peter Constable |
Apex (administrator, as referenced in NTA source notes) | Fund administration / NTA calculation (inferred from "Source: Bloomberg + Apex") | Third party |
Share registry | External provider (identity not captured in sources reviewed) | Third party |
Results by Segment and Revenue by Segment (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total investment income (AUD Mn) | 3.7 | 3.95 | 4.58 |
Profit before tax (AUD Mn) | — | 1.85 | -0.49 |
Total comprehensive income (AUD Mn) | 18.2 | 21.81 | 31.80 |
Share of total revenue (%) | 100 | 100 | 100 |
Sector Details
| Sector | Weight at 30 Jun 2026 (%) | Anchor holdings |
|---|---|---|
Materials | 20.8 | BCI Minerals, Polymetals, Hillgrove (Kantra Copper), Valiant Gold |
Financial Services | 20.1 | Count, Cuscal, OFX Group |
Technology | 18.9 | SiteMinder, Fineos, Gentrack, Vista, Airtasker, Janison, Urbanise, Updater |
Industrials | 13.0 | Chrysos, Symal, SRG Global, Duratec |
Healthcare | 12.3 | Vitrafy, Lumos Diagnostics, Tetratherix |
Cash | 6.9 | Includes settlements and receivables |
Consumer Discretionary | 3.8 | Adore Beauty, Coast Entertainment |
Media & Entertainment | 2.9 | Vista Group (cinema software, classification per manager) |
Energy | 1.2 | Amplitude Energy, Omega Oil & Gas |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total investment income (AUD Mn) | — | 3.2 | 3.7 | 3.95 | 4.58 |
Dividend income net of franking (AUD Mn) | — | — | — | 2.68 | 2.44 |
Interest income (AUD Mn) | — | — | — | 0.60 | 0.77 |
Management fees (AUD Mn) | — | — | — | 1.61 | 2.15 |
Performance fees (AUD Mn) | — | — | — | 0 | 2.18 |
Total expenses (AUD Mn) | — | — | — | 2.11 | 5.06 |
Profit before tax (AUD Mn) | — | — | — | 1.85 | -0.49 |
Income tax benefit (AUD Mn) | — | — | — | 0.37 | 0.92 |
Statutory net profit after tax (AUD Mn) | 3.48 | 1.51 | 2.03 | 2.22 | 0.43 |
OCI: fair value movement net of tax (AUD Mn) | — | — | — | 19.59 | 31.37 |
Total comprehensive income (AUD Mn) | — | — | 18.2 | 21.81 | 31.80 |
Basic and diluted EPS (AUD cents) | — | 1.8 | 2.4 | 2.72 | 0.53 |
Dividends declared per share (AUD cents) | 7.00 | 7.25 | 9.00 | 10.00 | 9.00 |
Dividends paid per share (AUD cents) | — | — | — | 9.5 | 11.5 |
Margin Analysis (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Expense ratio excl. performance fee (% of average net assets) | 1.75 | 2.09 |
Expense ratio incl. performance fee (% of average net assets) | 1.75 | 3.68 |
Total comprehensive income / average net assets (%) | 18.1 | 23.1 |
Statutory net profit / total investment income (%) | 56.1 | 9.4 |
Investment income growth YoY (%) | — | 15.7 |
Total comprehensive income growth YoY (%) | 20.0 | 45.8 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | — | — | 132.48 | 165.82 |
Cash and equivalents (AUD Mn) | — | — | 1.82 | 10.04 | 15.02 |
Investments at fair value (AUD Mn) | — | — | — | 121.88 | 150.74 |
Total debt / borrowings (AUD Mn) | — | — | — | 0 | 0 |
Net debt (AUD Mn; negative = net cash) | — | — | — | -10.04 | -15.02 |
Total liabilities (AUD Mn) | — | — | — | 5.79 | 17.36 |
Current tax liability (AUD Mn) | — | — | 0.55 | 5.40 | 8.33 |
Deferred tax liability, net (AUD Mn) | — | — | — | -0.28 | 2.74 |
Net assets / equity (AUD Mn) | — | 104.6 | 114.29 | 126.69 | 148.46 |
Goodwill and intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital: current assets less current liabilities (AUD Mn) | — | — | — | 4.60 | 1.89 |
Pre-tax NTA per share (AUD) | 1.36 | 1.19 | 1.3875 | 1.6272 | 1.9805 |
Post-tax NTA per share (AUD) | 1.40 | 1.25 | — | 1.5640 | 1.8430 |
Shares on issue (M) | — | — | 82.30 | 81.00 | 80.55 |
Distributable profit reserves per share (AUD) | — | — | — | 0.64 | 0.72 |
Components
| Component | Amount (AUD) |
|---|---|
Issued capital | 98,307,847 |
Accumulated losses | (12,720,390) |
Profits reserve | 10,180,019 |
Capital profits reserve | 47,612,271 |
Asset revaluation reserve | 5,077,508 |
Group Structure
| Level | Holdings | Amount (AUD) | Share of investments |
|---|---|---|---|
Level 1 | Listed equities | 139.83m | 92.8% |
Level 2 | FDC IPO shares and options | 4.99m | 3.3% |
Level 3 | Updater and Tubi | 5.91m | 3.9% |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net operating cash flow (AUD Mn) | — | 1.56 | 1.24 | -1.37 | -6.49 |
Income tax paid (AUD Mn) | — | — | — | 2.62 | 6.58 |
Proceeds from sale of investments (AUD Mn) | — | — | — | 81.17 | 90.62 |
Purchases of investments (AUD Mn) | — | — | — | 62.29 | 68.99 |
Net investing cash flow (AUD Mn) | — | 1 | -1 | 18.88 | 21.62 |
Capex (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Free cash flow: operating + net investing (AUD Mn) | — | 2.6 | 0.2 | 17.51 | 15.14 |
Dividends paid, cash net of DRP (AUD Mn) | 5.61 | 5.91 | 6.57 | 7.38 | 9.29 |
Share buy-backs, cash (AUD Mn) | — | — | — | 1.91 | 0.87 |
Net financing cash flow (AUD Mn) | — | -7 | -8 | -9.29 | -10.16 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2025 | FY2026 | Comment |
|---|---|---|---|
ROE on total comprehensive income (%) | 18.1 | 23.1 | Economic return on average equity |
ROE on statutory profit (%) | 1.8 | 0.3 | Distorted by FVOCI accounting |
ROA on total comprehensive income (%) | — | 21.3 | Average total assets FY26 = A$149.15m |
Current ratio (x) | 1.79 | 1.13 | FY26 inflated liabilities: A$3.92m broker settlements, A$2.18m performance fee, A$8.33m tax |
Debt / equity (x) | 0.00 | 0.00 | Ungeared |
Asset turnover: sales proceeds / average assets (x) | — | 0.61 | Portfolio turnover proxy |
Payout ratio: dividends paid / total comprehensive income (%) | 33.8 | 29.2 | Sustainable on an economic basis |
Margin Analysis (%) (FY2022–FY2026)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Pre-tax undiluted NTA return (%) | -21.47 | -8.85 | 24.96 | 27.16 | 33.40 |
Pre-tax diluted NTA return (%) | — | — | — | 27.50 | 33.53 |
Gross portfolio return (%) | — | — | — | 29.45 | 37.59 |
Hurdle: RBA cash + 4.25% (%) | — | — | — | 8.48 | 8.09 |
S&P/ASX Small Ords Accumulation (%) | — | — | — | — | 8.11 |
S&P/ASX All Ords Accumulation (%) | — | — | — | — | 5.70 |
Region Assets & Liabilities and Region Assets & Liabilities (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
USD-denominated financial assets (AUD Mn) | 2.65 | 6.76 |
AUD-denominated financial assets (AUD Mn) | 129.56 | 159.06 |
USD assets share of total financial assets (%) | 2.0 | 4.1 |
Share Price and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price (AUD) | 1.30 | 0.97 | 1.13 | 1.30 | 1.73 |
Pre-tax NTA per share (AUD) | 1.36 | 1.19 | 1.3875 | 1.6272 | 1.9805 |
Premium / (discount) to pre-tax NTA (%) | -4.4 | -18.5 | -18.6 | -20.1 | -12.6 |
Market capitalisation (AUD Mn) | — | 80.8 | 92.6 | 105.3 | 139.4 |
Total shareholder return (%) | — | -21.3 | 26.1 | 24.8 | 41.92 |
Valuation Snapshot
| Metric | Value |
|---|---|
Share price | A$2.14 |
Pre-tax / post-tax NTA | A$2.2395 / A$2.0175 |
Discount to pre-tax NTA | −4.4% |
Premium to post-tax NTA | +6.1% |
Market capitalisation | A$172.38m |
Cash | A$16.44m |
Enterprise value (market cap less cash) | About A$155.9m (analyst) |
Change by Period
| Period | Change | Basis |
|---|---|---|
~1 year | About +33% | A$1.61 at the 15 Oct 2025 release to A$2.14 at 30 Sep 2026 |
3 years | +78% | 30 Jun 2023 to 30 Jun 2026 |
5 years | Not available; 4-year +33% instead | — |
Valuation Multiples
| Multiple | RYD | Comment |
|---|---|---|
P/E (statutory) | About 400x | Not meaningful (FVOCI accounting) |
Price / total comprehensive income per share | About 5.4x | FY26 total comprehensive income of about 39.4 cps |
EV/Sales (investment income) | About 34x | Not meaningful |
P/B (price / pre-tax NTA) | 0.96x | Key LIC metric |
P/B (price / post-tax NTA) | 1.06x | — |
Cash dividend yield | 5.61% | — |
Grossed-up yield | About 8.0% | Analyst; 30% franking |
Per-Share Data and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividends declared (AUD cents per share) | 7.00 | 7.25 | 9.00 | 10.00 | 9.00 |
Franking (%) | 100 | 100 | 100 | 100 | 100 |
Capital Markets
| Item | Detail |
|---|---|
Buy-backs | On-market buy-back active. FY25: 1,641,386 shares for A$2.04m. FY26: 450,000 shares at an average A$1.65 (A$0.74m). None since about January 2026 and none in the Sep-26 quarter. The Board intends to buy back when it is meaningfully NTA-accretive. Authorisation limits n/d |
Credit ratings | None (Moody's, S&P and Fitch: not rated). No debt |
Debt maturity profile | Not applicable. All liabilities (A$17.36m at June 2026: trade payables, tax, deferred tax) are non-interest-bearing; financial liabilities are due within one month |
Analyst Conclusions
Management guidance
FY27 dividend: a minimum of 12.0 cps fully franked, paid quarterly.
Return outlook: the manager expects another strong year, citing several core holdings trading well below intrinsic value. It also warns that equities may underperform or be hard to navigate given:
-
Re-accelerating inflation
-
Central-bank tightening
-
The Middle East conflict
-
AI-driven disruption
Cash: to be rebuilt above the 8.85% September level by trimming overweight winners.
Buy-back: to resume only when accretive.
FY27 started at +14.88% for the September quarter.
Consensus
Not available (no broker coverage identified).
Bull case
-
Embedded catalysts. BCI (20% weight) moves from construction to cash flow, with first salt on ship in the March quarter of 2027 and the sulphate of potash pilot advancing. OFX completion at A$1.00 would add roughly A$4m (about 5 cps of NTA) versus the September mark. Vitrafy's US blood-network roll-out (about 18% of the addressable market already partnered) could re-rate a 7% position.
-
Proven process with a compounding track record. The since-inception profit-to-loss multiple of 4.80x, a 3-year return of 34.22% p.a. and a since-inception return of 12.98% p.a. (both diluted, to September 2026) suggest skill rather than luck. Rising cash gives optionality in a tightening market.
-
Income and structural support. A 72 cps distributable reserve and a A$19.3m adjusted franking balance underwrite a fully franked yield of 5.6% (about 8% grossed up). The narrowed discount (−4.4%) could flip to a premium, enabling accretive capital raising.
Bear case
-
Concentration and macro risk. With BCI at about 20% and the top seven positions at about 59%, a single project delay (cyclones already pushed out first salt) or a small-cap derating under a 4.60% cash rate could reverse gains quickly. 2H FY26 already delivered −8.88%.
-
Fee drag and governance. FY26 costs equalled about 3.7% of average net assets. The performance hurdle (cash + 4.25%) is easier to beat than an equity index in strong markets. With one independent director and an executive chair who controls the manager, minority shareholders have limited checks.
-
Valuation and deal fragility. OFX's financing uncertainty and FY27 downgrade (A$0.615 versus A$1.00 offer), Level 3 Updater marks (A$6.76m on a 17.5% discount-rate DCF), and recent software holdings that disappointed (Gentrack −73%; SiteMinder downgrade) show that mark-to-market gains are not locked in.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| 21 Oct 2026 | AGM: FY27 year-to-date update; director re-elections; any capital-management signals |
| By 30 Oct 2026 | OFX/Equals: debt financing, SID execution, scheme timetable |
| Monthly (about the 7th–10th) | NTA reports: discount/premium, cash level, BCI weight |
| Late Dec 2026 / early Jan 2027 | Q2 FY27 dividend (minimum 3.0 cps) |
| End of calendar 2026 | Vitrafy FDA registration/listing; Lumos US flu-season sales of FebriDX |
| Feb 2027 | 1H FY27 results (InvestSMART lists 18 Feb 2027) |
| Mar quarter 2027 | BCI first salt on ship at Mardie |
| Ongoing | RBA policy path; Updater revaluation; buy-back reactivation; any board-independence changes |
Concluding analyst verdict
Ryder Capital has evolved from a niche boutique LIC that endured two difficult years (FY22 −21.5%, FY23 −8.9%) into one of the best-performing listed equity vehicles on the ASX. It delivered three consecutive years of net returns above 25%, record total comprehensive income of A$31.8m in FY26, and a further +14.9% in the September 2026 quarter.
The quality of these returns is notable. The gains are driven by identifiable business progress (Count, Cuscal and Chrysos all posted record results, and BCI produced its first salt). Realised profits are high: A$36m net in FY26 alone. Risk-adjusted metrics materially exceed those of the indices. The board has converted that performance into a credible income proposition: a 12 cps fully franked dividend backed by about 72 cps of distributable reserves.
Against this, investors must accept a deliberately concentrated, high-volatility portfolio. BCI alone is about 20% of assets, and both the OFX takeover and the Level 3 Updater valuation carry completion and valuation risk. Fees are expensive by LIC standards. Governance falls short of ASX best-practice recommendations: an executive chair who controls the manager, a single independent director, and a cross-directorship with a top holding. The macro backdrop of rising rates, re-accelerating inflation and US$100 oil is unfriendly to small caps. At 0.96x pre-tax NTA, the historic discount buffer has largely disappeared.
The next 6–9 months should be binary-skewed positive: OFX completion and BCI's first shipment are tangible NTA catalysts. However, the stock's re-rating means new money is no longer buying at a discount. On balance, the evidence supports a constructive but valuation-aware stance. The key monitorables are OFX completion, BCI execution, cash rebuilding and any improvement in board independence.
Data limitations: - The supplied ISIN (US7835491082) relates to Ryder System, Inc. and does not identify this company.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed / tenure | Background | Education | Other listed boards |
|---|---|---|---|---|---|
Peter Constable | Executive Chairman; CIO of the Investment Manager; Audit & Risk Committee member | Director since 26 Jun 2015 (about 11 years); Executive Chairman since inception | 30+ years in equity capital markets. Began career in 1993 at United Bank of Kuwait, London. Founded AM Constable (1999), which merged with MMC Asset Management in 2003; CIO/ED of MMC to June 2008. Co-founded Ryder Investment Management in July 2008 | BEc (Macquarie University) | — |
Lauren De Zilva CFA | Executive Director; Portfolio Manager; Audit & Risk Committee member | Appointed 4 March 2025 (about 1.6 years); joined Ryder in 2018 | 8+ years in equity markets; previously an intern at Commonwealth Bank of Australia | BActSt, BAppFin (Macquarie University); CFA charterholder; GAICD | — |
David Bottomley | Non-Executive Director; Audit & Risk Committee member | Director since 26 Jun 2015. Executive Director to 4 Mar 2025, then NED. Retired as Company Secretary 4 Mar 2025 | 25+ years in corporate finance, M&A and ECM. Kleinwort Benson (UK), Merrill Lynch (London), MD Australia of GMCG LLC (2004–2008). Co-founder of the Investment Manager; ceased as its director 10 Mar 2025 | BA (Economic History, University of Sydney), LLB (Hons, Bond University), F Fin | None current; Tetratherix Ltd director March 2020 to December 2025 |
Ray Kellerman | Independent Non-Executive Director; Chair of Audit & Risk Committee | Appointed June 2015 (about 11 years) | 35+ years in funds management and structured finance. Ten years at Perpetual Trustees; own compliance consultancy since 2001. Former Independent Chair of ClearView Wealth and of Credit Suisse Asset Management Australia | BEc, LLB, MBA, F Fin | Chairman of Count Limited (ASX: CUP), director since January 2017 |
Executive Leadership Team
| Name | Role |
|---|---|
Peter Constable | Chairman and Chief Investment Officer |
Lauren De Zilva CFA | Portfolio Manager and Director |
Alex Grosset | Assistant Portfolio Manager |
Directors' Remuneration
| Director | FY26 fees | FY26 super | FY26 total | FY25 total |
|---|---|---|---|---|
Peter Constable | 0 | 0 | 0 | 0 |
Lauren De Zilva | 0 | 0 | 0 | 0 |
David Bottomley | 35,714 | 4,286 | 40,000 | 10,000 |
Ray Kellerman | 35,714 | 4,286 | 40,000 | 40,000 |
Total | 71,428 | 8,572 | 80,000 | 50,000 |
Directors' Remuneration (FY25 (AUD)–FY26 (AUD))
| Fee | FY26 (AUD) | FY25 (AUD) |
|---|---|---|
Management fee | 2,151,756 | 1,608,380 |
Performance fee | 2,179,125 (payable after the FY26 audit) | 0 |
Directors' Remuneration (FY2022–FY2026)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total directors' remuneration (AUD K) | 40 | 40 | 40 | 50 | 80 |
Governance Overview
| Attribute | Assessment |
|---|---|
Board size | 4 |
Independent directors | 1 of 4 (Kellerman) |
Chair / CEO separation | No. The Chairman is also CIO of the external manager, which does not meet ASX Corporate Governance Council Recommendations 2.4 and 2.5 (majority independent board; independent chair) |
Committees | Audit & Risk Committee: all four directors, chaired by Kellerman. No separate nomination or remuneration committee disclosed |
Meetings FY26 | Board 3 of 3 attended by all directors; ARC 2 of 2 attended by all |
Cross-directorship | Kellerman chairs Count Limited, Ryder's second-largest holding (8.25% at June 2026; 8.80% at September 2026). This is a potential conflict requiring careful information-barrier management |
Related-party exposure | Bottomley was a Tetratherix director (to Dec 2025) while Ryder participated in the July 2025 Tetratherix IPO. The FY26 report notes that the manager knew Tetratherix through the Ryder Innovation Fund |
Auditor rotation | Grant Thornton replaced by Pitcher Partners for FY26 (reason not disclosed) |
Board & Management Changes
| Date | Change |
|---|---|
4 Mar 2025 | De Zilva appointed Executive Director; Bottomley moves to NED and retires as Company Secretary |
10 Mar 2025 | Bottomley ceases as director of the Investment Manager |
May 2026 | Jane Corish appointed Company Secretary. The interim secretary between March 2025 and May 2026 was not identified in the sources reviewed |
Major Shareholders
| Holder | Shares | % of 80,549,795 |
|---|---|---|
Peter Constable (incl. 4,194,000 held by the Investment Manager) | 13,495,832 | 16.75 |
David Bottomley | 2,950,000 | 3.66 |
Ray Kellerman | 1,800,000 | 2.23 |
Lauren De Zilva | 64,997 | 0.08 |
Total directors and related | 18,310,829 | 22.73 |
Competitive Landscape
Key Competitors
| # | Competitor (ASX code) | Manager | Strategy overlap | Relative positioning vs RYD |
|---|---|---|---|---|
| 1 | WAM Microcap (WMI) | Wilson Asset Management | ASX micro-caps | Larger, more diversified, highly liquid retail franchise |
| 2 | WAM Capital (WAM) | Wilson Asset Management | Small/mid-cap, market-driven plus research | Much larger; flagship retail LIC |
| 3 | WAM Research (WAX) | Wilson Asset Management | Small/mid-cap research-driven | Larger; dividend-focused |
| 4 | NAOS Small Cap Opportunities (NSC) | NAOS Asset Management | Concentrated, engaged small-cap | Most similar concentrated style; has faced discount and performance pressure |
| 5 | NAOS Emerging Opportunities (NCC) | NAOS | Concentrated micro-cap | Similar style |
| 6 | Thorney Opportunities (TOP) | Thorney Investment Group | Concentrated, activist small-cap | Similar high-conviction, manager-aligned model |
| 7 | Spheria Emerging Companies (SEC) | Spheria Asset Management | Small/micro-cap value | Value-style peer |
| 8 | Sandon Capital Investments (SNC) | Sandon Capital | Activist small-cap | Engagement-driven peer |
| 9 | Mirrabooka Investments (MIR) | AFIC group | Small/mid-cap long-term | Low-cost, internally managed, larger |
| 10 | Unlisted small-cap funds (e.g. boutique small-cap unit trusts and active ETFs) | Various | Small-cap | Daily liquidity at NAV; no discount risk |
Competitor Detail
| Metric | Ryder Capital (RYD) |
|---|---|
Net assets / gross assets (AUD Mn) | 148.5 (Jun-26); 185.7 gross (Sep-26) |
FY26 pre-tax NTA return (%) | 33.53 |
3-year pre-tax NTA return (% p.a., Sep-26) | 34.22 |
Management fee (% p.a.) | 1.25 + GST |
Performance fee | 20% over RBA + 4.25% |
Price / pre-tax NTA (Sep-26) | 0.96x |
Recent Developments
Not identified in the sources reviewed: * litigation, regulatory actions, layoffs or restructurings.



